
- /
- Supported exchanges
- / US
- / ACOG.NASDAQ
Alpha Cognition Inc (ACOG NASDAQ) stock market data APIs
Alpha Cognition Inc Financial Data Overview
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Alpha Cognition Inc data using free add-ons & libraries
Get Alpha Cognition Inc Fundamental Data
Alpha Cognition Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -11 834 435
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.74
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Alpha Cognition Inc News

Alpha Cognition enters $75 million at-the-market offering agreement with Wainwright
Alpha Cognition Inc. (NASDAQ:ACOG) announced Friday that it has entered into an At the Market Offering Agreement with H.C. Wainwright & Co., LLC to offer and sell common shares with an aggregate gross...


Alpha Cognition files $250M mixed securities shelf
* Alpha Cognition (NASDAQ:ACOG [https://seekingalpha.com/symbol/ACOG]) filed $250M mixed securities shelf. * Filing [https://seekingalpha.com/filing/10335419] MORE ON ALPHA COGNITION * Alpha C...

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease
VANCOUVER, British Columbia & DALLAS, July 29, 2025--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition" [ACI], or the "Company"), a biopharmaceutical company developing novel ther...

H.C. Wainwright reiterates Buy rating on Alpha Cognition stock, citing promising mTBI data
Investing.com - H.C. Wainwright has maintained its Buy rating and $20.00 price target on Alpha Cognition Inc (NASDAQ:ACOG), representing an 87% upside from the current price of $10.69. The stock has s...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.